ATE469661T1 - Methode zu der konditionierung einer saüle mit avidin oder streptavidin matrix in einer vorrichtung ausserhalb des körpers - Google Patents

Methode zu der konditionierung einer saüle mit avidin oder streptavidin matrix in einer vorrichtung ausserhalb des körpers

Info

Publication number
ATE469661T1
ATE469661T1 AT01941404T AT01941404T ATE469661T1 AT E469661 T1 ATE469661 T1 AT E469661T1 AT 01941404 T AT01941404 T AT 01941404T AT 01941404 T AT01941404 T AT 01941404T AT E469661 T1 ATE469661 T1 AT E469661T1
Authority
AT
Austria
Prior art keywords
conditioning
avidin
column
device outside
streptavidin matrix
Prior art date
Application number
AT01941404T
Other languages
English (en)
Inventor
Bengt Sandberg
Scott Wilbur
Rune Nilsson
Original Assignee
Mitra Medical Technology Ab
Dept Of Radiation Oncology Uni
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0002287A external-priority patent/SE0002287D0/xx
Application filed by Mitra Medical Technology Ab, Dept Of Radiation Oncology Uni filed Critical Mitra Medical Technology Ab
Application granted granted Critical
Publication of ATE469661T1 publication Critical patent/ATE469661T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804—Affinity chromatography
    • B01D15/3823—Affinity chromatography of other types, e.g. avidin, streptavidin or biotin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • External Artificial Organs (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT01941404T 2000-06-16 2001-06-18 Methode zu der konditionierung einer saüle mit avidin oder streptavidin matrix in einer vorrichtung ausserhalb des körpers ATE469661T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0002287A SE0002287D0 (sv) 2000-06-16 2000-06-16 Biotinderivat
US21662500P 2000-07-07 2000-07-07
PCT/SE2001/001374 WO2001095857A2 (en) 2000-06-16 2001-06-18 Reusable extracorporeal colums loaded with ligand-dibiotin conjugates

Publications (1)

Publication Number Publication Date
ATE469661T1 true ATE469661T1 (de) 2010-06-15

Family

ID=26655149

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01941404T ATE469661T1 (de) 2000-06-16 2001-06-18 Methode zu der konditionierung einer saüle mit avidin oder streptavidin matrix in einer vorrichtung ausserhalb des körpers

Country Status (14)

Country Link
EP (1) EP1289563B1 (de)
JP (1) JP2004503299A (de)
CN (1) CN1457260A (de)
AT (1) ATE469661T1 (de)
AU (2) AU7476101A (de)
BR (1) BR0111726A (de)
CA (1) CA2412495C (de)
DE (1) DE60142286D1 (de)
HU (1) HUP0401953A3 (de)
IL (1) IL153449A0 (de)
MX (1) MXPA02012438A (de)
NO (1) NO20025931L (de)
PL (1) PL359328A1 (de)
WO (1) WO2001095857A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1813614T3 (da) * 2006-01-25 2012-01-23 Sanofi Sa Cytotoksiske midler, der omfatter nye tomaymycinderivater
BRPI0820156B8 (pt) * 2007-11-12 2021-05-25 Chreto Aps processo para purificação de uma biomolécula alvo
DK2714685T3 (en) * 2011-05-27 2017-01-09 Ambrx Inc FORMATIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID BOUND dolastatin
KR20200128601A (ko) * 2011-05-27 2020-11-13 암브룩스, 인코포레이티드 비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
WO2015125820A1 (ja) * 2014-02-18 2015-08-27 サヴィッド・セラピューティックス株式会社 ビオチン改変体、ストレプトアビジン変異体およびそれらの利用
CN106166311B (zh) * 2016-08-30 2018-07-13 张小曦 一种血浆净化系统及其应用
KR20210126135A (ko) 2016-12-27 2021-10-19 에프. 호프만-라 로슈 아게 신규한 비오틴-특이적 단일클론 항체 및 그 용도
KR102413013B1 (ko) * 2016-12-27 2022-06-23 에프. 호프만-라 로슈 아게 신규한 비오틴-특이적 단일클론 항체 및 그 용도
JP6982075B2 (ja) 2016-12-27 2021-12-17 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft 新規のビオチン特異的モノクローナル抗体およびその使用
WO2018151301A1 (ja) * 2017-02-17 2018-08-23 三井化学株式会社 抗体医薬の開発に資する創薬標的タンパク質の同定方法及び標的タンパク質に対する抗体の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5482698A (en) * 1993-04-22 1996-01-09 Immunomedics, Inc. Detection and therapy of lesions with biotin/avidin polymer conjugates
JP3441530B2 (ja) * 1994-10-03 2003-09-02 株式会社セルシード 温度応答型分離材料及びその製造方法
JP3300583B2 (ja) * 1995-11-10 2002-07-08 幹男 中山 抗原又は抗体の検出シート、検出キット及び検出方法
WO1997029114A1 (en) * 1996-02-08 1997-08-14 Board Of Regents Of The University Of Washington Biotin-containing compounds, biotinylation reagents and methods

Also Published As

Publication number Publication date
AU7476101A (en) 2001-12-24
IL153449A0 (en) 2003-07-06
DE60142286D1 (de) 2010-07-15
EP1289563A2 (de) 2003-03-12
HUP0401953A2 (hu) 2004-12-28
CA2412495C (en) 2011-02-01
JP2004503299A (ja) 2004-02-05
BR0111726A (pt) 2003-05-27
EP1289563B1 (de) 2010-06-02
MXPA02012438A (es) 2004-09-06
WO2001095857A2 (en) 2001-12-20
NO20025931D0 (no) 2002-12-11
PL359328A1 (en) 2004-08-23
AU2001274761B2 (en) 2005-06-16
HUP0401953A3 (en) 2005-06-28
CN1457260A (zh) 2003-11-19
NO20025931L (no) 2003-02-14
CA2412495A1 (en) 2001-12-20
WO2001095857A3 (en) 2002-03-28

Similar Documents

Publication Publication Date Title
WO2007001342A3 (en) Exhaled breath condensate collection and assay system and method
EP1578354A4 (de) Targets, verfahren und reagenzien für die diagnose und behandlung von schizophrenie
BRPI0417417A (pt) sistema de coleta de amostra de inibidor de fosfatase
BRPI0515758A (pt) dispositivo de ensaio de diagnóstico
DE69908776D1 (de) Vorrichtung zur handhabung von körperflüssigkeiten, die körperflüssigkeiten durch absaugen transportiert
ATE442590T1 (de) Verfahren zur schnelldiagnose von zielen in menschlichen kírperflüssigkeiten
BR0316969A (pt) Tratamento de mal de huntington com epa
ATE440629T1 (de) Kanüleneinführungssystem
EP0505479A4 (de)
DE60142286D1 (de) Methode zu der konditionierung einer saüle mit avidin oder streptavidin matrix in einer vorrichtung ausserhalb des körpers
BR0010068A (pt) Sistema de identificação do marcador fenotìpico e biológico
DK2332582T3 (da) ACE2-aktivering til behandling af hjerte-, lunge-og nyresygdomme samt forhøjet blodtryk
EP1619206A3 (de) Gewebeinhibitor der Matrix-Metalproteinase Typ 1 (TIMP-1) als Krebsmarker
WO2002085185A3 (en) Hydrophilic diagnostic devices
FR2810679B1 (fr) Procede d'extraction d'americium, de curium et de lanthanides de solutions acides
SE0002287D0 (sv) Biotinderivat
PL1750596T3 (pl) Element łączący do wprowadzania do środka struktury kostnej ciała człowieka lub zwierzęcia i związany z nim system lokalizujący
DE50115166D1 (de) System zur einfachen Nukleinsäureanalytik
WO1992002819A3 (en) Assay for ulcerative colitis and primary sclerosing cholangitis
EP1451552A4 (de) Zum nachweisen von erkrankungen der brust geeignete reagenzien und verfahren
WO2022017968A3 (en) Method for treating a liquid sample comprising a diagnostic assay reagent after use
WO2004071273A3 (en) Method of employing elevation of marinobufagenin in determining the presence of preeclampsia and related apparatus
DE3683101D1 (de) Mit ueberzuegen versehene formkoerper zur bindung von bioaffinen substanzen.
TR200201011T2 (tr) Akışkan işleme cihazı
WO2001048476A3 (de) Gewinnung von biologischen komponenten aus körperflüssigkeiten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties